Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease

Len Usvyat, Lorien Dalrymple, Franklin W. Maddux

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Summary: Consistent with the increase of precision medicine, the care of patients with end-stage kidney disease (ESKD) requiring maintenance dialysis therapy should evolve to become more personalized. Precise and personalized care is nuanced and informed by a number of factors including an individual's needs and preferences, disease progression, and response to and tolerance of treatments. Technology can support the delivery of more precise and personalized care through multiple mechanisms, including more accurate and real-time assessments of key care elements, enhanced treatment monitoring, and remote monitoring of home dialysis therapies. Data from health care and non–health care sources and advanced analytical methods such as machine learning can be used to create novel insights, and large volumes of data can be integrated to support clinical decisions. Health care models continue to evolve and the opportunities and need for novel care approaches supported by technology and health informatics continue to expand as the delivery and organization of health care changes. Ultimately, precise personalized care for ESKD, including dialysis therapy, will become more feasible as the biological, social, and environmental determinants of health are more broadly understood and as advances in science, engineering, and information management create the means to provide truly precise care for ESKD.

Original languageEnglish (US)
Pages (from-to)418-425
Number of pages8
JournalSeminars in Nephrology
Volume38
Issue number4
DOIs
StatePublished - Jul 1 2018
Externally publishedYes

Fingerprint

Chronic Kidney Failure
Patient Care
Technology
Dialysis
Delivery of Health Care
Clinical Decision Support Systems
Social Determinants of Health
Therapeutics
Information Management
Precision Medicine
Biomedical Technology
Informatics
Environmental Health
Disease Progression
Maintenance
Organizations

Keywords

  • artificial intelligence
  • dialysis
  • individualized medicine
  • precise personalized care
  • renaldisease
  • Technology

ASJC Scopus subject areas

  • Nephrology

Cite this

Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease. / Usvyat, Len; Dalrymple, Lorien; Maddux, Franklin W.

In: Seminars in Nephrology, Vol. 38, No. 4, 01.07.2018, p. 418-425.

Research output: Contribution to journalReview article

Usvyat, Len ; Dalrymple, Lorien ; Maddux, Franklin W. / Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease. In: Seminars in Nephrology. 2018 ; Vol. 38, No. 4. pp. 418-425.
@article{4838dfa12c4e4dfa8574e31186f4a333,
title = "Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease",
abstract = "Summary: Consistent with the increase of precision medicine, the care of patients with end-stage kidney disease (ESKD) requiring maintenance dialysis therapy should evolve to become more personalized. Precise and personalized care is nuanced and informed by a number of factors including an individual's needs and preferences, disease progression, and response to and tolerance of treatments. Technology can support the delivery of more precise and personalized care through multiple mechanisms, including more accurate and real-time assessments of key care elements, enhanced treatment monitoring, and remote monitoring of home dialysis therapies. Data from health care and non–health care sources and advanced analytical methods such as machine learning can be used to create novel insights, and large volumes of data can be integrated to support clinical decisions. Health care models continue to evolve and the opportunities and need for novel care approaches supported by technology and health informatics continue to expand as the delivery and organization of health care changes. Ultimately, precise personalized care for ESKD, including dialysis therapy, will become more feasible as the biological, social, and environmental determinants of health are more broadly understood and as advances in science, engineering, and information management create the means to provide truly precise care for ESKD.",
keywords = "artificial intelligence, dialysis, individualized medicine, precise personalized care, renaldisease, Technology",
author = "Len Usvyat and Lorien Dalrymple and Maddux, {Franklin W.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.semnephrol.2018.05.011",
language = "English (US)",
volume = "38",
pages = "418--425",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease

AU - Usvyat, Len

AU - Dalrymple, Lorien

AU - Maddux, Franklin W.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Summary: Consistent with the increase of precision medicine, the care of patients with end-stage kidney disease (ESKD) requiring maintenance dialysis therapy should evolve to become more personalized. Precise and personalized care is nuanced and informed by a number of factors including an individual's needs and preferences, disease progression, and response to and tolerance of treatments. Technology can support the delivery of more precise and personalized care through multiple mechanisms, including more accurate and real-time assessments of key care elements, enhanced treatment monitoring, and remote monitoring of home dialysis therapies. Data from health care and non–health care sources and advanced analytical methods such as machine learning can be used to create novel insights, and large volumes of data can be integrated to support clinical decisions. Health care models continue to evolve and the opportunities and need for novel care approaches supported by technology and health informatics continue to expand as the delivery and organization of health care changes. Ultimately, precise personalized care for ESKD, including dialysis therapy, will become more feasible as the biological, social, and environmental determinants of health are more broadly understood and as advances in science, engineering, and information management create the means to provide truly precise care for ESKD.

AB - Summary: Consistent with the increase of precision medicine, the care of patients with end-stage kidney disease (ESKD) requiring maintenance dialysis therapy should evolve to become more personalized. Precise and personalized care is nuanced and informed by a number of factors including an individual's needs and preferences, disease progression, and response to and tolerance of treatments. Technology can support the delivery of more precise and personalized care through multiple mechanisms, including more accurate and real-time assessments of key care elements, enhanced treatment monitoring, and remote monitoring of home dialysis therapies. Data from health care and non–health care sources and advanced analytical methods such as machine learning can be used to create novel insights, and large volumes of data can be integrated to support clinical decisions. Health care models continue to evolve and the opportunities and need for novel care approaches supported by technology and health informatics continue to expand as the delivery and organization of health care changes. Ultimately, precise personalized care for ESKD, including dialysis therapy, will become more feasible as the biological, social, and environmental determinants of health are more broadly understood and as advances in science, engineering, and information management create the means to provide truly precise care for ESKD.

KW - artificial intelligence

KW - dialysis

KW - individualized medicine

KW - precise personalized care

KW - renaldisease

KW - Technology

UR - http://www.scopus.com/inward/record.url?scp=85050849406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050849406&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2018.05.011

DO - 10.1016/j.semnephrol.2018.05.011

M3 - Review article

VL - 38

SP - 418

EP - 425

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 4

ER -